Loading...
Loading...
shares dropped 36.64% to $8.94 in pre-market trading after the company announced the removal of the FDA partial clinical hold on VB-111. VBL Therapeutics announced its plans to discontinue the development of VB-201 in ulcerative colitis and psoriasis following Phase 2 results.
Walter Energy, Inc.WLT shares declined 9.17% to $0.99 in pre-market trading after the company reported a wider-than-expected Q4 loss.
Cablevision Systems Corporation CVC fell 3.11% to $19.96 in pre-market trading after gaining 1.58% on Friday.
Applied Materials, Inc AMAT shares fell 1.70% to $23.71 in pre-market trading after dropping 0.08% on Friday
Macy's, Inc.M shares dropped 1.26% to $63.51 in pre-market. Analysts at Barclays initiated coverage on Macy's with a Underweight rating.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsConsumer DiscretionaryDepartment StoresTop Losers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in